
|Articles|February 3, 2022
UBC Partners with Seqster
Advertisement
UBC has partnered with Seqster PDM, Inc. to provide health record interoperability with patient engagement. UBC will utilize the technology to enable clinical and observational research to transition from traditional site-based studies to decentralized clinical trials. Seqster’s turnkey white label solution facilitates the move to a fully decentralized approach with automated data acquisition and abstraction.
Read more about the partnership
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
2
Beyond Compliance: ProofPilot's Joseph Kim and Lauren Briggs on Making Clinical Trial Training Actually Work
3
ACT Brief: Efficacy Ceiling Breakthrough in Autoimmune Disease, Early-Career Retention and Burnout Prevention, and PRV Program Catalyzing Rare Disease Investment
4
Breaking the Efficacy Ceiling in IBD and Beyond
5



